Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Enterobacter aerogenes ZDY01 inhibits choline-induced atherosclerosis through CDCA-FXR-FGF15 axis
Jinghui
Tang†
ab,
Manman
Qin†
ab,
Le
Tang
ab,
Dan
Shan
ab,
Cheng
Zhang
c,
Yifeng
Zhang
ab,
Hua
Wei
d,
Liang
Qiu
*ab and
Jun
Yu
*c
aKey Laboratory for Pharmacology and Translational Research of Traditional Chinese Medicine of Nanchang, Centre for Translational Medicine, Jiangxi University of Chinese Medicine, Nanchang 330006, China. E-mail: liangqiu@jxutcm.edu.cn; Fax: +86-791-87119895; Tel: +86-791-87119895
bJiangxi Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Vascular Remodelling Diseases, China
cDepartment of Physiology and Centre for Metabolic Disease Research, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA. E-mail: jun.yu@temple.edu
dState Key Laboratory of Food Science and Technology, Nanchang University, Nanchang, Jiangxi 330047, P. R. China
First published on 15th December 2021
Abstract
Correction for ‘Enterobacter aerogenes ZDY01 inhibits choline-induced atherosclerosis through CDCA-FXR-FGF15 axis’ by Jinghui Tang et al., Food Funct., 2021, 12, 9932–9946, DOI: 10.1039/D1FO02021H.
The authors regret that there was an error with the author details in the original article. The first two authors should be marked as co-first authors.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
Footnote |
| † These authors are co-first authors. |
| This journal is © The Royal Society of Chemistry 2022 |